These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 318239)

  • 1. [Potency testing of inactivated rabies vaccines. Problems posed by the use of the Habel test].
    Aubert MF; Andral L
    Comp Immunol Microbiol Infect Dis; 1979; 1(4):341-9. PubMed ID: 318239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Am J Vet Res; 2003 Apr; 64(4):499-505. PubMed ID: 12693543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay.
    Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR
    J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH test, a problematic method for testing potency of inactivated rabies vaccine.
    Barth R; Diderrich G; Weinmann E
    Vaccine; 1988 Aug; 6(4):369-77. PubMed ID: 3188617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potency test which simulates natural exposure for measuring post-exposure activity of rabies vaccines. A proposal for preparing a relevant international reference preparation.
    Bijlenga G
    Dev Biol Stand; 1978; 40():203-8. PubMed ID: 567153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.
    Liu Y; Zhang S; Zhang F; Hu R
    Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated rabies vaccine control and release: use of an ELISA method.
    Fournier-Caruana J; Poirier B; Haond G; Jallet C; Fuchs F; Tordo N; Perrin P
    Biologicals; 2003 Mar; 31(1):9-16. PubMed ID: 12623055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.
    Nunberg JH; Doyle MV; York SM; York CJ
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4240-3. PubMed ID: 2786210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency testing of inactivated rabies vaccines using a serological method.
    Kamphuis E; Krämer B; Schildger H; Duchow K
    Dev Biol (Basel); 2012; 134():23-7. PubMed ID: 22888591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mortality in mice infected with rabies virus and subsequently vaccinated against rabies.
    Blancou J; Sitte D
    Comp Immunol Microbiol Infect Dis; 1988; 11(2):139-42. PubMed ID: 2972508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
    Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties and potency of a rabies vaccine produced on the brain matter of young goats and inactivated by beta-propiolactone].
    Mansour AB; Abrous M
    Dev Biol Stand; 1978; 41():217-24. PubMed ID: 753652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questions concerning the potency of rabies vaccine.
    Crick J; Brown F
    Dev Biol Stand; 1978; 40():179-82. PubMed ID: 355012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modifications of the habel test].
    Barth R; Jaeger O
    Zentralbl Bakteriol Orig; 1969; 209(3):279-88. PubMed ID: 5379826
    [No Abstract]   [Full Text] [Related]  

  • 19. A step forward in the quality control testing of inactivated rabies vaccines - extensive evaluation of European vaccines by using alternative methods to the in vivo potency tests.
    Servat A; Kempff S; Brogat V; Litaize E; Schereffer JL; Cliquet F
    Altern Lab Anim; 2015 Mar; 43(1):19-27. PubMed ID: 25802995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production.
    Joffret ML; Zanetti C; Morgeaux S; Leclerc C; Sureau P; Perrin P
    Biologicals; 1991 Apr; 19(2):113-23. PubMed ID: 1888490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.